Yubo International Biotech Ltd Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Yubo International Biotech Ltd quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Yubo International Biotech Ltd Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $579K, a 18.1% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $579K +$88.7K +18.1% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $499K -$61.6K -11% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $292K -$375K -56.3% Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $392K -$399K -50.4% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $491K -$1.71M -77.7% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $561K -$1.84M -76.6% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $667K -$2.11M -75.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $790K -$1.9M -70.7% Dec 31, 2022 10-K 2024-04-12
Q3 2022 $2.2M -$139K -5.92% Sep 30, 2022 10-Q 2022-11-16
Q2 2022 $2.4M +$346K +16.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $2.77M +$830K +42.8% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $2.69M +$2.38M +755% Dec 31, 2021 10-K 2023-04-14
Q3 2021 $2.34M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $2.05M Jun 30, 2021 10-Q 2021-08-20
Q1 2021 $1.94M Mar 31, 2021 10-Q 2021-05-24
Q4 2020 $315K Dec 31, 2020 10-K 2022-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.